SLC31A1 and ovarian carcinoma: Subsequent studies have shown that cisplatin-sensitive A2780 ovarian carcinoma cells have higher CTR1 expression than cisplatin-resistant A2780CP[14] and that overexpression of CTR1 in A2780 cells increased the influx of cisplatin[15].